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Edited by Michael R. BubbAbstract Premature ageing, one of the characteristics of Down
syndrome (DS), may involve oxidative stress and impairment of
proteasome activity. Transgenic mice overexpressing the human
copper/zinc superoxide dismutase (SOD1) gene are one of the
ﬁrst murine models for DS and it has been shown that SOD1
overexpression might be either deleterious or beneﬁcial. Here,
we show a reduction in proteasome activities in the cortex of
SOD1 transgenic mice and an associated increase in the content
of oxidized SOD1 protein. As we demonstrate that in vitro oxi-
dized SOD can inhibit puriﬁed proteasome peptidase activities,
modiﬁed SOD1 might be partially responsible for proteasome
inhibition shown in SOD1 transgenic mice.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Down syndrome (DS) is characterized by the presence of a
third set of the chromosome 21 genes. Mental retardation,
and age related features such as Alzheimer-type neuroanato-
mopathology, premature thymic involution, skin dryness and
early cataract are features of this condition [1].
Human copper/zinc superoxide dismutase (h-SOD1) is one
of the main antioxidant enzymes, which catalyzes the dismuta-
tion of the superoxide anion into hydrogen peroxide. Its gene
was one of the ﬁrst chromosome 21 genes identiﬁed [2]. Trans-Abbreviations: CML, Ne-(carboxymethyl)lysine; DS, Down syndrome;
ROS, reactive oxygen species; h-SOD1, human SOD1; SOD1, copper/
zinc superoxide dismutase; SODx, SOD oxidized with x lM FeSO4
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model for DS [3,4]. It has been proposed that enhanced oxida-
tive stress in DS results from the overexpression of SOD1
which could increase levels of hydrogen peroxide [5,6]. Prema-
ture thymic involution, similar to the early thymic involution
observed in DS, was shown in h-SOD1 transgenic mice [7]
and enhanced sensitivity of thymocytes to LPS cell death by
apoptosis was attributed to an increased oxidative stress [8].
More recently, reactive oxygen species (ROS) were shown to
induce thymus apoptosis in Ts65Dn mice which fulﬁll the cri-
teria for a DS model [9]. Oxidative stress, DNA and protein
damages are important factors in many pathological processes
[10,11]. In particular, enhanced oxidative stress and oxidized
proteins have been reported as a causal role in numerous neu-
rodegeneration studies [12].
The proteasome represents the main constituent of the pro-
teolytic pathway for the degradation of oxidized proteins and
is composed of at least three distinct peptidase activities: chy-
motrypsin-like, trypsin-like and capase-like activities [13].
While the role of the proteasome in the central nervous system
(CNS) is poorly understood, its activity may play an important
role in maintaining neuronal homeostasis and in degradating
oxidized proteins [14]. Increasing evidence suggests that the
activity of the proteasome can be altered under conditions of
enhanced oxidative stress [15,16].
Here, we aimed to determine whether in vivo SOD1 overex-
pression could result in modiﬁcation of proteasome peptidase
activities and promote accumulation of oxidized proteins in
CNS. Oxidative modiﬁcations and decreased proteasomal pep-
tidase activities were found in the cortices of h-SOD1 trans-
genic mice at diﬀerent ages as compared with control mice.
Moreover, inﬂuence of in vitro oxidized h-SOD1 showed an
inhibitory eﬀect on two out of three peptidases activities of
puriﬁed rat proteasome.2. Materials and methods
2.1. Animals
Generation of transgenic mice harboring the human SOD1
(h-SOD1) gene has been described previously [17]. Homozygous trans-
genic (h-SOD1/h-SOD1) and control mice (+/+) aged 7 and 15 months
and 24 months old hemizygous mice (h-SOD1/+), were on the same
FVB/N background. Mice were maintained on a 12 h:12 h dark:light
cycle, with food and water ad libitum. All experimental procedures
with animals were approved by the University Animal Careblished by Elsevier B.V. All rights reserved.
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tory Animals. The SOD1 activity in cortices from the h-SOD1 trans-
genic mice was 6–8 fold that of controls (data not shown).
2.2. Homogenate preparations
Cortices were dissected from mice and stored at 80 C. For protea-
some activity assays, cortices were homogenized with an ultraturax
homogenizer in 500 ll buﬀer (20 mM HEPES, 0.1 mM EDTA,
1 mM 2-mercapto-ethanol, pH 7.8), centrifuged at 12000 · g for
12 min at 4 C. Protein concentration was determined with Bradford
reagent (Biorad).2.3. Proteasome activity measurements
Chymotrypsin-like, trypsin-like, and caspase-like activities of the
proteasome were assayed using the ﬂuorogenic peptides (from Sigma)
Suc-Leu-Leu-Val-Tyr-7-amido-4-methylcoumarin (LLVY-MCA at
25 lM), N-t-Boc-Leu-Ser-Thr-Arg-7-amido-4-methylcoumarin
(LSTR-MCA at 40 lM) and N-Cbz-Leu-Leu-Glu-b-naphthylamide
(LLE-NA at 150 lM), respectively [13]. Assays were carried out with
30–50 lg of cortex lysates or 5 lg of the 20S puriﬁed rat proteasome
in 25 mM Tris–HCl (pH 7.5) and the appropriate substrate at 37C
for 0–30 min incubation. The ﬂuorescence of the samples was evalu-
ated using a Bio-Tek Kontron SFM 25 spectroﬂuorimeter at excita-
tion/emission wavelengths of 350/440 and 333/410 nm for
aminomethylcoumarin and b-naphthylamine products, respectively.
Peptidase activities were measured in the absence or in the presence
(20 lM) of the proteasome inhibitor MG132 (N-Cbz-Leu-Leu-leuci-
nal) and the diﬀerence between the two values was attributed to pro-
teasome activity. For in vitro experiments, the 20S proteasome was
puriﬁed from rat livers according to Bulteau et al. [15].
2.4. Immunoprecipitation
Immunoprecipitations were performed, following the Santa Cruz
Biotechnology instructions, by incubating 1 mg/ml protein lysates ex-
tracted from the cortices of 7 months old SOD1 overexpressing mice
(SS or control mice WT) or an equal volume of PBS (sample No. 0)
with 2 lg of rabbit polyclonal anti-human SOD1 antibodies or rabbit
polyclonal anti-mouse IgG as controls (Santa Cruz Biotechnology).
Immunocomplexes were pelleted with 20 ll protein-G PLUS agarose
(Santa Cruz Biotechnology).
2.5. In vitro oxidation of SOD1 and measurements of SOD1 enzymatic
activity
SOD1 puriﬁed from human erythrocytes (Sigma) at 0.1 mg/ml was
incubated with 0, 10, 50, 100, 200, 500 and 800 lM of freshly prepared
FeSO4, in PBS, pH 7.4. Freshly prepared ascorbate (1 M in PBS) was
added at a ﬁnal concentration of 25 mM to the solutions which were
incubated at 37 C for 2 h. Reactions were stopped by removing iron
and ascorbate by extensive dialysis against PBS, pH 7.4, at 4 C.
SOD1 activities were measured using a superoxide dismutase kit
(R&D Systems).
2.6. Western blots
Carbonylated proteins from total cortices and from h-SOD1 immu-
noprecipated proteins were analyzed using the Oxyblot kit (Oxyblot
Detection, Chemicon International Inc) [18]. Brieﬂy, samples were
treated with 10 mM 2,4-dinitrophenylhydrazine in 2 M HCl, incubated
at room temperature and neutralized. The derivatized proteins were
separated by SDS/PAGE, transferred to a nitrocellulose membrane.
The primary antibody used was against 2,4-dinitrophenol and detec-
tion was performed using the ECL reagent (Amersham-Biosciences).
Ne-(carboxymethyl)lysine (CML) proteins were detected by Western
blot in total cortices lysates (20 lg protein) after electrophoresis on
12% (w/v) SDS/PAGE. Proteins were transferred to a nitrocellulose
membrane (Amersham-Bioscience) which was incubated overnight at
4 C with polyclonal antibodies puriﬁed from CML-BSA immunized
rabbits for the detection of CML (1:2000) obtained in our laboratory
[19].
h-SOD1, 20Sproteasomeandb-actinwere detectedbyWesternblot in
total cortices. Protein (20 lg) were transferred to a nitrocellulose mem-
brane which was incubated with polyclonal goat anti-h-SOD1 (1:2000,
Calbiochem), rabbit anti-20S proteasome antibodies (1:2000, obtained
in our laboratory) and mouse monoclonal b-actin (1:2000, Sigma).2.7. Statistical analyses
Statistical signiﬁcances were determined using Students t test, with a
P value of less than 0.05 required for signiﬁcance using GraphPad
Prism Software. Multi Gauge V2.02 software has been used for Wes-
tern blot quantiﬁcations.3. Results
3.1. Alterations in peptidase activities in the cortex of h-SOD1
overexpressing mice
Proteasome peptidase activities were assayed in the cytosolic
extracts of cortices from 7-, 15- and 24-month-old mice. As
shown in Fig. 1, trypsin-like and capase-like activities were re-
duced in the cortices of h-SOD1 mice in comparison to the
control ones. By contrast, no signiﬁcant reduction in the
chymotrypsin-like activities was observed. The reduction per-
centages of the proteasome trypsin-like activities measured in
h-SOD1 cortex versus control mice were 46% (P < 0.01),
40.4% (P<0.05) and 22.6% (P < 0.05) for 7-, 15- and 24-
month-old mice, respectively, and those for the caspase-like
activities, were 14.3%, 32.6% (P < 0.05) and 14.1%
(P < 0.01), respectively.3.2. Oxidative modiﬁcation of SOD in the cortex of h-SOD1
overexpressing mice
Carbonyl groups in proteins are one of the features of oxi-
dized proteins [19]. Analysis of cytosolic extracts from cortex
tissue by this method revealed an increase in the level of oxida-
tively modiﬁed proteins in the samples prepared from h-SOD1
overexpressing mice (Fig. 2A). This result correlates with an
increase in a 16 kDa band in the transgenic tissues (Fig. 2C)
suggesting that h-SOD1 exhibits carbonyl groups mostly in
transgenic mice. Indeed, carbonyl assays performed on
SOD1 immunoprecipitates, showed that h-SOD1 gets oxidized
in transgenic mice (Fig. 3). Scans of the carbonyl content
showed that transgenic tissues contain much more carbonyl
than controls. Moreover there was an increase in SOD content
demonstrating more oxidized SOD present in transgenic tis-
sues than in wild type (data not shown).
Amongst the diﬀerent advanced glycated end products
(AGEs), we detected a high signal of CML especially for pro-
teins in the same kDa range as h-SOD1 (Fig. 2B and C). The
fact that the same band was increased in both CML and Wes-
tern blot experiments is in favor of SOD1 being targeted for
both oxidative and glycoxidative modiﬁcations. Conversely,
the 20S proteasome expression was similar in transgenic and
control mice (Fig. 2D). This indicates that the impairment of
the trypsin-like and capase-like activities in the cortices of h-
SOD1 transgenic mice were not due to a decrease in the pro-
teasome levels.3.3. In vitro oxidation of h-SOD1
As the loss of proteasome activities in the cortices of
h-SOD1 transgenic mice could be related to the presence of
h-SOD1 protein, we determined whether in vitro oxidized h-
SOD1 could aﬀect the activities of rat puriﬁed proteasome.
Modiﬁed h-SOD1 preparations obtained by incubation with
increasing concentrations of FeSO4 were evaluated for their
carbonyl groups content (Fig. 4A). Carbonyls groups were
dramatically increased, especially for SOD50, SOD100 and
SOD200 and this increase was accompanied by a strong de-
* *
**
*
**
0
7 15 24
7 15 24
R
el
at
iv
e 
ac
tiv
ity
 %
AGE (months)
0
100
50
AGE (months)
R
el
at
iv
e 
ac
tiv
ity
%
R
el
at
iv
e 
ac
tiv
ity
%
100
50
Trypsin-like Activity
Chymotrypsin-like Activity
AGE (months)
50
100
50
Caspase-like Activity
Wild type +/+
Tg SS
7 1 24
Fig. 1. Eﬀects of SOD overexpression on proteasome peptidase activities in the cortices. Trypsin-like, capase-like, chymotrypsin-like activities were
evaluated in the homogenates of cortices from transgenic (SS) and control mice (+/+) using the ﬂuorogenic peptides as described in Section 2. The
results are expressed as percentage of the activities (7 months control mice = 100%). The signiﬁcance of the results, expressed as mean ± S.D., n = 3,
was determined by comparison of the values for SS mice in black boxes versus +/+ mice in white boxes using Students t test for unpaired samples:
\P < 0.05, \\ P < 0.01.
Fig. 2. Western blot detection of oxidatively modiﬁed proteins,
h-SOD1, 20S proteasome and b-actin in the cortex lysates. Cytosolic
extracts were prepared from cortices of 7 and 15 month-old +/+ and SS
mice. Oxidatively modiﬁed proteins (A) were detected with the
Oxyblot-kit (Chemicon International Inc.). Western blot analysis was
performed utilizing polyclonal anti CML (B). (C), 20S proteasome (D)
and the murine b-actin were detected by Western blot analyses (E).
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carbonyl on in vitro modiﬁed h-SOD1 preparations were also
performed by spectrophometric assay (Cayman). Values rises
from no detectable levels for SOD0, to 0.0026, 0.032 and
0.047 mol of carbonyl per mol of SOD for SOD100, SOD500
and SOD800, respectively.
3.4. Impairment of puriﬁed proteasome trypsine-like and
caspase-like activities by oxidized h-SOD1
The trypsin-like activity of the puriﬁed proteasome was
strongly impaired in the presence of SOD10, SOD50, SOD100
and SOD200 with a decrease of 18% (P < 0.05), 32%
(P < 0.01), 44% (P < 0.01) and 55% (P < 0.01), respec-
tively, in comparison with native SOD1 (Fig. 4C).
The capase-like activity was also decreased with a 35%
(P < 0.01) and a 73% (P < 0.01) for SOD500 and SOD800,Fig. 3. Western blot detection of oxidatively modiﬁed proteins
following SOD1 immunoprecipitation. Western blot analysis was
performed on h-SOD1 immunoprecipitated brain lysates from 7
months old +/+ or SS mice using the oxyblot kit accordingly to
Section 2.
Fig. 4. In vitro oxidation of h-SOD1. (A) Detection of modiﬁed h-SOD1 after incubation with FeSO4. SOD1 protein puriﬁed from human
erythrocytes (0,1 mg/ml) was incubated with 25 mM ascorbate and 0, 10, 50, 100 and 200 lM FeSO4 at 37 C for 2 h. Western blot analysis was
performed utilizing polyclonal antibodies against 2,4-dinitrophenol following the manufactorys instructions. (B) Eﬀect of SOD1 oxidation on SOD1
activity. h-SOD1 was incubated with 0, 10, 50, 100, 200 lM FeSO4 at 37 C for 2 h. After extensive dialyses, SOD1 activity was assayed with the
R&D systems kit. Results are the mean of three diﬀerent experiments. The signiﬁcance of the results, expressed as mean ± S.D., was determined by
comparison of the values for h-SOD1 incubated in the presence of iron (SODx) versus h-SOD1 incubated in the absence of the metal (SOD0) using
Students t test for unpaired samples: \ P < 0.05, \\P < 0.01. (C) Eﬀects of oxidized SOD on peptidase activities of puriﬁed proteasome. Trypsin-,
capase- and chymotrypsin-like activities of 5 lg of puriﬁed proteasome were evaluated in the absence or the presence of 15 lg of h-SOD1 (5 lM
SOD1), previously incubated with 0, 10, 50, 100, 200, 500 and 800 lMFeSO4 at 37 C for 2 h. The results are expressed as percentage of the activities
of the proteasome incubated in the presence of native h-SOD1. The signiﬁcance of the results, expressed as mean ± S.D., n = 3, was determined by
comparison of the values for SOD incubated in the presence of iron (SODx) versus SOD without the metal (SOD0) using Students t test for unpaired
samples: \P < 0.05, \\P < 0.01.
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like activity was observed.
To check if the apparent decrease in trypsin- and caspase-
like activities might be due to direct proteasome inhibition,
we realized the same incubations as for the proteasome mea-surements in the presence of similar oxidized SOD prepara-
tions and performed Western blot using SOD1 antibodies to
detect the amount of SOD1 protein, which has not been de-
graded by the proteasome activity. No decrease in the amount
of remaining SOD1 was observed after incubation of oxidized
Fig. 5. SOD1 levels after reaction with proteasome substrates. 5 lg of puriﬁed proteasome were incubated in the presence of the diﬀerent
preparations of oxidized SOD as in Fig. 1 and in the presence of LLVY-MCA (25 lM) or LLE-NA (150 lM) in 25 mM Tris–HCl at 37 C for
30 min. Then, we performed Western blot using SOD1 antibodies in order to detect the amount of SOD1 non degraded by the proteasome.
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(150 lM) or LLVY-MCA (25 lM) (Fig. 5). As this amount
is either increased or unchanged, it is conceivable that oxidized
SOD1 would not be a better substrate for proteasome activity
than non-oxidized SOD1. Since only oxidized SOD1 inhibits
proteasome activity (Fig. 4C), this means that this impairment
to the proteolytic system can not be due to more eﬀective sub-
strate competition by oxidized SOD1 relative to non-oxidized
SOD1.4. Discussion
Oxidative modiﬁcations of proteins and antioxidants have
been shown to be important in the development and the possi-
ble treatment of various neurodegenerative diseases [11,20–22].
There are still a lot of questions concerning the consequences
either protective or destructive of SOD1 overexpression in
DS [23]. The present study was undertaken to determine
whether SOD1 overexpression in the brain could alter, during
aging, the function of the proteasome, and thus the removal of
oxidatively damaged proteins. Inhibition of proteasome activ-
ity during ageing has already been described in rat models [24].
Few data are available on the inﬂuence of wild type h-SOD1
overexpression on proteasome activities. Aquilano et al. [25]
showed an enhanced proteasomal activity in transfected neuro-
blastoma cells overexpressing the G93A h-SOD1 mutant sug-
gesting a cross talk between ROS and nitrogen species via
the proteasome pathway. Recent data show proteasome inhibi-
tion in mutant or wild type SOD1 transgenic models [26,27]. In
our experimental conditions, wild type h-SOD1 expression in
the cortices of transgenic mice was shown to decrease protea-
some activities in comparison with controls.
To better understand the origin of the inhibition of protea-
some activities in h-SOD1 transgenic tissues, we correlated this
decrease with an increase in oxidatively modiﬁed SOD1 car-
bonyl content as assessed by carbonyl Western blot analysis
together with a dramatic increase in CML-modiﬁed proteins
(Fig. 2). It is well known that the central nervous system is
highly aerobic and its antioxidant defences are relatively low,
in particular having almost no catalase [28]. Thus, it is easily
conceivable that the overproduction of h-SOD1 in the brain
of the transgenic mice could result in a strong generation of
hydrogen peroxide which is not readily removed by catalaseor/and glutathione peroxidase, then giving rise to the deleteri-
ous hydroxyl radical via the Fenton reaction [29]. We previ-
ously showed by carbonyl measurements that several
proteins became selectively oxidized when the cells were trea-
ted in the presence of iron and accumulated in the presence
of the proteasome inhibitor lactacystin [30]. Amongst the iden-
tiﬁed proteins, SOD1 appeared to be particularly susceptible to
oxidation, as assayed by carbonyl measurement.
As in vivo inhibition of proteasome activity was associated
with increase levels of oxidized h-SOD1 in the cortices of trans-
genic mice, the inﬂuence of in vitro oxidized h-SOD1 was
examined on the activity of puriﬁed proteasome. Oxidized
SOD1 markedly reduced the trypsin-like and capase-like activ-
ities of the proteasome whereas it did not aﬀect, in our exper-
imental conditions, its chymotrypsin-like activity. Conversely,
our results show that the proteasome chymotrypsin-like activ-
ity was neither aﬀected by in vitro modiﬁed h-SOD1 nor by the
in vivo h-SOD1 expression in cortices of transgenic mice.
It has been reported that oxidized SOD can be a substrate
for proteasome [31]. If it was so, then a decreased level of
SOD1 would have been observed when proteasome was incu-
bated with the oxidized forms of SOD1 (Fig. 5). It was also re-
ported by the same group, that exposure of proteasome to
oxidized protein leads to a biphasic response in the proteolytic
activities, where ‘‘at moderate oxidant concentrations proteo-
lytic susceptibility increases, whereas at higher oxidant concen-
tration, a decrease (sometimes even below the ‘‘basal
degradation’’ level) in proteolytic susceptibility occurs’’ [31].
This could be in agreement with the protective or destructive
activities of SOD1 [23]. In our experimental conditions, the
inhibition of proteasome by in vitro highly oxidized SOD
could not be due to a competition of the oxidized SOD with
the peptide substrate.
Also, impaired proteasome activities, observed in our sys-
tem, was mostly not due to a direct competition since oxidized
SOD did not bind to speciﬁc ﬂuorescent peptides used for pro-
teolytic activities measurements (data not shown).
The roles of SOD1 overexpression and animal models in DS
studies have been poorly evaluated at the biochemical level.
Our work deals with the eﬀects of SOD1 overexpression on
the proteasome in the cortices of transgenic mice. We propose
that oxidation of SOD1 could occur in vivo in the cortices
of SOD1 overexpressing mice and might impair, at least, par-
tially the proteasome activities. Further experiments will be
3618 M.L. Pecheur et al. / FEBS Letters 579 (2005) 3613–3618performed to assay if this inhibition could occur also in other
tissues from h-SOD1 transgenic mice and to better characterize
the mechanism of this proteasome inhibition.
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